Figure 3

Growth of Tumor #2 is also significantly inhibited during treatment with Apo2L/TRAIL. A. Control; B. Apo2L/TRAIL treated. (4 mice/group; day 35, p = 0.016). Following cessation of treatment (arrows), growth of treated tumors progressed at a rate similar to that of the untreated tumors.